[go: up one dir, main page]

CO5070658A1 - USEFUL THERAPEUTIC AGENTS FOR THE TREATMENT AND PREVENTION OF CARDIO VASCULAR DISEASES IN POSMENOPAUSIAN WOMEN - Google Patents

USEFUL THERAPEUTIC AGENTS FOR THE TREATMENT AND PREVENTION OF CARDIO VASCULAR DISEASES IN POSMENOPAUSIAN WOMEN

Info

Publication number
CO5070658A1
CO5070658A1 CO97051289A CO97051289A CO5070658A1 CO 5070658 A1 CO5070658 A1 CO 5070658A1 CO 97051289 A CO97051289 A CO 97051289A CO 97051289 A CO97051289 A CO 97051289A CO 5070658 A1 CO5070658 A1 CO 5070658A1
Authority
CO
Colombia
Prior art keywords
women
posmenopausian
prevention
treatment
therapeutic agents
Prior art date
Application number
CO97051289A
Other languages
Spanish (es)
Inventor
Jeremy N Bradbeer
Maxine Gowen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5070658A1 publication Critical patent/CO5070658A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Un método para tratar y prevenir la enfermedad cardiovascular posmenopáusica en mujeres, que comprende administrar a una paciente necesitada de ello, una cantidad eficaz de un compuesto de fórmula I.Un uso según la reivindicación 4, en el que el compuesto de fórmula I es (E)-1-[2-[4-[1-(4-yodofenil )-2-fenil-1-butenil ] fenoxi ] pirrolidina.A method for treating and preventing postmenopausal cardiovascular disease in women, comprising administering to a patient in need thereof, an effective amount of a compound of formula I. A use according to claim 4, wherein the compound of formula I is ( E) -1- [2- [4- [1- (4-iodophenyl) -2-phenyl-1-butenyl] phenoxy] pyrrolidine.

CO97051289A 1996-09-06 1997-09-04 USEFUL THERAPEUTIC AGENTS FOR THE TREATMENT AND PREVENTION OF CARDIO VASCULAR DISEASES IN POSMENOPAUSIAN WOMEN CO5070658A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24

Publications (1)

Publication Number Publication Date
CO5070658A1 true CO5070658A1 (en) 2001-08-28

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
CO97051287A CO4920218A1 (en) 1996-09-06 1997-09-04 THERAPEUTIC AGENTS BASED ON IDOXIFENO, USEFUL IN THE TREATMENT OF OSTEOPOROSIS
CO97051289A CO5070658A1 (en) 1996-09-06 1997-09-04 USEFUL THERAPEUTIC AGENTS FOR THE TREATMENT AND PREVENTION OF CARDIO VASCULAR DISEASES IN POSMENOPAUSIAN WOMEN

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CO97051287A CO4920218A1 (en) 1996-09-06 1997-09-04 THERAPEUTIC AGENTS BASED ON IDOXIFENO, USEFUL IN THE TREATMENT OF OSTEOPOROSIS

Country Status (16)

Country Link
EP (2) EP0927029A4 (en)
JP (2) JP2002515047A (en)
KR (2) KR20000068473A (en)
CN (2) CN1236313A (en)
AR (1) AR008155A1 (en)
AU (2) AU4409797A (en)
BR (2) BR9711676A (en)
CA (2) CA2264775A1 (en)
CO (2) CO4920218A1 (en)
CZ (1) CZ76699A3 (en)
IL (1) IL128645A0 (en)
NO (2) NO991097L (en)
PL (2) PL332038A1 (en)
TR (2) TR199900504T2 (en)
TW (1) TW411273B (en)
WO (2) WO1998009619A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5749998A (en) * 1997-02-11 1998-08-26 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (en) * 1999-02-12 2000-08-17 Stefan Neubauer Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (en) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifen derivatives
ES2112994T3 (en) * 1992-09-15 1998-04-16 Merrell Pharma Inc NON METABOLIZABLE ANALOGS OF CLOMIFENE USED IN THE TREATMENT OF TAMOXIFENO RESISTANT TUMORS.
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
AU6277396A (en) * 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
EP0929216A4 (en) 2001-04-04
EP0929216A1 (en) 1999-07-21
CN1236313A (en) 1999-11-24
AR008155A1 (en) 1999-12-09
NO991097D0 (en) 1999-03-05
CZ76699A3 (en) 1999-08-11
EP0927029A4 (en) 2001-06-13
BR9711676A (en) 1999-08-24
NO991096D0 (en) 1999-03-05
IL128645A0 (en) 2000-01-31
PL332278A1 (en) 1999-08-30
NO991097L (en) 1999-03-05
AU4247397A (en) 1998-03-26
JP2002515047A (en) 2002-05-21
TR199900504T2 (en) 1999-06-21
EP0927029A1 (en) 1999-07-07
TW411273B (en) 2000-11-11
CA2264943A1 (en) 1998-03-12
CO4920218A1 (en) 2000-05-29
TR199900506T2 (en) 1999-07-21
KR20000068473A (en) 2000-11-25
AU4409797A (en) 1998-03-26
BR9711681A (en) 1999-08-24
PL332038A1 (en) 1999-08-16
JP2002515046A (en) 2002-05-21
KR20000068472A (en) 2000-11-25
CA2264775A1 (en) 1998-03-12
CN1236299A (en) 1999-11-24
WO1998009519A1 (en) 1998-03-12
NO991096L (en) 1999-03-05
WO1998009619A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
ES2086270T3 (en) METABOLITES OF TERFENADINE AND ITS OPTICALLY PURE ISOMERS TO TREAT ALLERGIC DISORDERS.
EA200300036A1 (en) COMBINATION OF DIPEPTIDYLPEPIDIDASE INHIBITORS IV AND OTHER ANTI-DIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS
BR0212252A (en) Methods to Reduce Hypertension and Heart Failure in a Mammal
RU94044436A (en) Method of suppression of skin and vagina atrophy
ES2164916T3 (en) TREATMENT OF MULTIPLE SCLEROSIS.
ATE241378T1 (en) COMBINATIONS OF VASOPRESSIN AND ADRENERGIC ACTIVES FOR THE TREATMENT OF SUDDEN CARDIAC DEATH
BG97068A (en) PHARMACEUTICAL COMPOSITION AND METHOD OF ACHIEVING THERAPEUTIC EFFECT
NO179250C (en) Analogous Process for Preparation of Therapeutically Active (+) - (2,3-Dimethoxyphenyl) -1- [2- (4-Fluorophenyl) Ethyl α-4-Piperidinemethanol
SE9404196D0 (en) New antithrombotic formulation
YU32196A (en) Application of compound for preparation of medicine useful for inhibiting vascular smooth muscle cell migration
RU94044490A (en) Use of 2-phenyl-3-aroylbenzothiophenes for defective tissue recovery suppression
DE69327263D1 (en) Use of the tissue factor inhibitor for the manufacture of a medicament against microvascular thrombosis
ES2157960T3 (en) PROCEDURE TO INCREASE THE LIBIDO IN POSTMENOPAUSIC WOMEN.
ES2161238T3 (en) USE OF 2-PHENYL-3-AROILBENZOTIOPHENES FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INHIBIT ANGIOGENESIS AND ANGIOGENIC DISEASES.
ES2171889T3 (en) AGENT REDUCING CHOLESTEROL IN SERUM.
RU94044489A (en) Use of 2-phenyl-3-aroylbenzothiophenes for myeloperoxidase activity inhibition
EA199800717A1 (en) METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION
CO5070658A1 (en) USEFUL THERAPEUTIC AGENTS FOR THE TREATMENT AND PREVENTION OF CARDIO VASCULAR DISEASES IN POSMENOPAUSIAN WOMEN
FI950403A0 (en) Neurosprotective compounds
FR2714828B1 (en) Application of riluzole in the treatment of mitochondrial diseases.
DE69904465D1 (en) THERAPY OF DEPRESSIONS
EE04658B1 (en) New potential for use of the Ridazinone derivative
DE69729201T2 (en) SULFON FLUORIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
RU94044487A (en) Use of 2-phenyl-3-aroylbenzothiophenes for male sterility treatment
ES2101311T3 (en) USE OF A TRANSDERMIC DEVICE CONTAINING (E) -2- (P-FLUOROFENETIL) -3-FLUOROALILAMINA AND ITS USE FOR THE TREATMENT OF ALZHEIMER DISEASE.